Format

Send to

Choose Destination
Cell Med. 2017 Apr 14;9(3):103-116. doi: 10.3727/215517917X693401. eCollection 2017.

Human Adipose-Derived Mesenchymal Stem Cells Respond to Short-Term Hypoxia by Secreting Factors Beneficial for Human Islets In Vitro and Potentiate Antidiabetic Effect In Vivo.

Author information

1
Department of Transplant Medicine, Oslo University Hospital, Oslo, Norway.
2
†Institute for Surgical Research, Oslo University Hospital, Oslo, Norway.
3
‡Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
4
§Section for Cell Therapy, Oslo University Hospital, Oslo, Norway.
5
¶Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway.
6
#Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
7
*Department of Surgery, Oslo University Hospital, Oslo, Norway.
8
††Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Abstract

Adipose-derived mesenchymal stem cells (ASCs) release factors beneficial for islets in vitro and protect against hyperglycemia in rodent models of diabetes. Oxygen tension has been shown to induce metabolic changes and alter ASCs' release of soluble factors. The effects of hypoxia on the antidiabetic properties of ASCs have not been explored. To investigate this, we incubated human ASCs for 48 h in 21% (normoxia) or 1% O2 (hypoxia) and compared viability, cell growth, surface markers, differentiation capability, and soluble factors in the conditioned media (CM). Human islets were exposed to CM from ASCs incubated in either normoxia or hypoxia, and islet function and apoptosis after culture with or without proinflammatory cytokines were measured. To test hypoxic preconditioned ASCs' islet protective effects in vivo, ASCs were incubated for 48 h in normoxia or hypoxia before being injected into Balb/c Rag 1-/- immunodeficient mice with streptozotocin-induced insulitis. Progression of diabetes and insulin content of pancreas were measured. We found that incubation in hypoxia was well tolerated by ASCs and that levels of VEGF-A, FGF-2, and bNGF were elevated in CM from ASCs incubated in hypoxia compared to normoxia, while levels of HGF, IL-8, and CXCL1 were reduced. CM from ASCs incubated in hypoxia significantly improved human islet function and reduced apoptosis after culture, and reduced cytokine-induced apoptosis. In our mouse model, pancreas insulin content was higher in both groups receiving ASCs compared to control, but the mice receiving preconditioned ASCs had lower random and fasting blood glucose, as well as improved oral glucose tolerance compared to untreated mice. In conclusion, our in vitro results indicate that the islet protective potential of ASCs improves in hypoxia, and we give insight into factors involved in this. Finally we show that hypoxic preconditioning potentiates ASCs' antidiabetic effect in vivo.

KEYWORDS:

Adipose-derived stem cells (ASCs); Diabetes; Hypoxia; Islet transplantation

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central Icon for Norwegian BIBSYS system
Loading ...
Support Center